Entries tagged Tumor Suppressor Protein p53/chemistry/physiology (35)

  3415: Dutchak et al. (2012) "Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones." Cell 148(3):556-567 (PubMed)

  3759: Yang et al. (2006) "The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis." Proc. Natl. Acad. Sci. U.S.A. 103(44):16472-16477 (PubMed)

  2177: Greenhalgh et al. (2005) "SOCS2 negatively regulates growth hormone action in vitro and in vivo." J. Clin. Invest. 115(2):397-406 (PubMed)

  930: Savinov et al. (2003) "Contribution of Fas to diabetes development." Proc. Natl. Acad. Sci. U.S.A. 100(2):628-632 (PubMed)

  2484: Jia et al. (2007) "Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans." Autophagy 3(1):21-25 (PubMed)

  1610: Payne et al. (2006) "Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle." J. Physiol. (Lond.) 570(Pt 2):283-294 (PubMed)

  1915: Dai et al. (2007) "Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis." Cell 130(6):1005-1018 (PubMed)

  2926: Lee et al. (2000) "Gene-expression profile of the ageing brain in mice." Nat. Genet. 25(3):294-297 (PubMed)

  680: Fletcher et al. (1996) "Absence epilepsy in tottering mutant mice is associated with calcium channel defects." Cell 87(4):607-617 (PubMed)

  755: Cummings et al. (2001) "Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice." Hum. Mol. Genet. 10(14):1511-1518 (PubMed)

  1533: Chen et al. (2005) "Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis." Nature 436(7051):725-730 (PubMed)

  1611: Darnaudéry et al. (2006) "Insulin-like growth factor 1 reduces age-related disorders induced by prenatal stress in female rats." Neurobiol. Aging 27(1):119-127 (PubMed)

  1811: Patturajan et al. (2002) "DeltaNp63 induces beta-catenin nuclear accumulation and signaling." Cancer Cell 1(4):369-379 (PubMed)

  2175: Dey et al. (1998) "Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor." J. Biol. Chem. 273(37):24095-24101 (PubMed)

  269: Naka et al. (1998) "Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice." Proc. Natl. Acad. Sci. U.S.A. 95(26):15577-15582 (PubMed)

  449: Nakayama et al. (1994) "Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia." Proc. Natl. Acad. Sci. U.S.A. 91(9):3700-3704 (PubMed)

  2115: Hasegawa et al. (2012) "Blockade of the nuclear factor-κB pathway in the endothelium prevents insulin resistance and prolongs life spans." Circulation 125(9):1122-1133 (PubMed)

  2119: Li et al. (2008) "Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells." J. Cell. Physiol. 217(2):377-387 (PubMed)

  2176: Favre et al. (1999) "Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction." FEBS Lett. 453(1-2):63-66 (PubMed)

  1100: Tranchant et al. (2003) "Phenotypic variability of aprataxin gene mutations." Neurology 60(5):868-870 (PubMed)